Human Delta-lactoferrin is a Transcription Factor That Enhances Skp1 (S-phase Kinase-associated Protein) Gene Expression
Overview
Authors
Affiliations
Delta-lactoferrin is a cytoplasmic lactoferrin isoform that can locate to the nucleus, provoking antiproliferative effects and cell cycle arrest in S phase. Using macroarrays, the expression of genes involved in the G(1)/S transition was examined. Among these, Skp1 showed 2-3-fold increased expression at both the mRNA and protein levels. Skp1 (S-phase kinase-associated protein) belongs to the Skp1/Cullin-1/F-box ubiquitin ligase complex responsible for the ubiquitination of cellular regulators leading to their proteolysis. Skp1 overexpression was also found after delta-lactoferrin transient transfection in other cell lines (HeLa, MDA-MB-231, HEK 293) at comparable levels. Analysis of the Skp1 promoter detected two sequences that were 90% identical to those previously known to interact with lactoferrin, the secretory isoform of delta-lactoferrin (GGCACTGTAC-S1(Skp1), located at - 1067 bp, and TAGAAGTCAA-S2(Skp1), at - 646 bp). Both gel shift and chromatin immunoprecipitation assays demonstrated that delta-lactoferrin interacts in vitro and in vivo specifically with these sequences. Reporter gene analysis confirmed that delta-lactoferrin recognizes both sequences within the Skp1 promoter, with a higher activity on S1(Skp1). Deletion of both sequences totally abolished delta-lactoferrin transcriptional activity, identifying them as delta-lactoferrin-responsive elements. Delta-lactoferrin enters the nucleus via a short bipartite RRSDTSLTWNSVKGKK(417-432) nuclear localization signal sequence, which was demonstrated to be functional using mutants. Our results show that delta-lactoferrin binds to the Skp1 promoter at two different sites, and that these interactions lead to its transcriptional activation. By increasing Skp1 gene expression, delta-lactoferrin may regulate cell cycle progression via control of the proteasomal degradation of S-phase actors.
Dierick M, Ongena R, Vanrompay D, Devriendt B, Cox E Pharmaceutics. 2022; 14(9).
PMID: 36145526 PMC: 9504966. DOI: 10.3390/pharmaceutics14091778.
The Lactoferrin Phenomenon-A Miracle Molecule.
Kowalczyk P, Kaczynska K, Kleczkowska P, Bukowska-Osko I, Kramkowski K, Sulejczak D Molecules. 2022; 27(9).
PMID: 35566292 PMC: 9104648. DOI: 10.3390/molecules27092941.
Lactoferrin as a Human Genome "Guardian"-An Overall Point of View.
Bukowska-Osko I, Sulejczak D, Kaczynska K, Kleczkowska P, Kramkowski K, Popiel M Int J Mol Sci. 2022; 23(9).
PMID: 35563638 PMC: 9105968. DOI: 10.3390/ijms23095248.
Grieshaber-Bouyer R, Radtke F, Cunin P, Stifano G, Levescot A, Vijaykumar B Nat Commun. 2021; 12(1):2856.
PMID: 34001893 PMC: 8129206. DOI: 10.1038/s41467-021-22973-9.
Saitou M, Gaylord E, Xu E, May A, Neznanova L, Nathan S Cell Rep. 2020; 33(7):108402.
PMID: 33207190 PMC: 7703872. DOI: 10.1016/j.celrep.2020.108402.